TRNR Earnings Interactive Strength, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–22 of 22
| Q2 2026 | 2026-06-30 | -17.37 | 2026-08-14 | 10-Q |
| Q1 2026 | 2026-03-31 | -71.68 | 2026-05-20 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | 379.66 | 2026-03-31 | 10-K |
| FY 2025 | 2025-12-31 | -1202.39 | 2026-03-31 | 10-K |
| Q3 2025 | 2025-09-30 | -217.70 | 2025-11-14 | 10-Q |
| Q2 2025 | 2025-06-30 | -149.29 | 2025-08-14 | 10-Q |
| Q1 2025 | 2025-03-31 | -1215.06 | 2025-05-19 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | 1887869.94 | 2025-03-31 | 10-K |
| FY 2024 | 2024-12-31 | -114299.50 | 2025-03-31 | 10-K |
| Q3 2024 | 2024-09-30 | -107419.20 | 2024-11-14 | 10-Q |
| Q2 2024 | 2024-06-30 | -17476.24 | 2024-08-14 | 10-Q |
| Q1 2024 | 2024-03-31 | -1877274.00 | 2024-05-20 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | -11626836.72 | 2024-04-01 | 10-K |
| FY 2023 | 2023-12-31 | -11630395.00 | 2024-04-01 | 10-K |
| Q3 2023 | 2023-09-30 | -2054.50 | 2023-11-14 | 10-Q |
| Q2 2023 | 2023-06-30 | -40.78 | 2023-08-14 | 10-Q |
| Q1 2023 | 2023-03-31 | -1463.00 | 2023-06-09 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | 32450.40 | — | — |
| FY 2022 | 2022-12-31 | -83643.00 | — | — |
| Q3 2022 | 2022-09-30 | -84448.00 | — | — |
| Q2 2022 | 2022-06-30 | -978.40 | — | — |
| Q1 2022 | 2022-03-31 | -30667.00 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.